[O13] Oral Session 13"Cancer 2"

[O13-4] Oncolytic virotherapy improves resistance to paclitaxel in pancreatic cancer by suppressing MDR1 expression

^○Hiroaki Inoue¹, Hiroshi Tazawa^1,2, Yasuo Nagai¹, Satoru Kikuchi¹, Shinji Kuroda¹, Yasuo Urata³, Shunsuke Kagawa¹, Toshiyoshi Fujiwara¹ (1.Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 2.Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan, 3.Oncolys BioPharma, Inc., Tokyo, Japan)